Biochip allows genes to express themselves

Biochip platforms that work as artificial cells are attractive for medical diagnostics, interrogation of biological processes, and for the production of important biomolecules. However, to match the complexity of nature, the biochips need to be designed such that proteins, DNA, and other important biological components can be located in specific, spatially well-defined regions on the chips.

This allows these devices to mimic the complex, sequential, and often cascaded events involved in biological processes. Now, in a major breakthrough, a group of researchers at the Weizmann Institute of Science in Israel, led by Roy Bar-Ziv, in collaboration with Margherita Morpurgo from the University of Padova in Italy, have designed a molecule affectionately called the “daisy” that is able to bind genes onto chips in miniature patterned arrays.

Bar-Ziv and co-workers have been able to use the daisy to pattern tiny regions of double-stranded DNA onto silicon dioxide surfaces. Indeed, these immobilized genes are able to conduct their business on patterned silicon substrates without the need for living cells. These biochips can act as protein microtraps, selectively trapping specific proteins from crude cell extracts with high spatial resolution. Moreover, the gene sequences immobilized on the biochips can be used for the on-chip production of proteins by transcription/translation processes such as those occurring within cells.

Bar-Ziv and his colleagues have also demonstrated the integration of these systems with microfluidics. Integration with flow systems is of interest for the fabrication of miniature assembly lines on chips, wherein proteins can be synthesized on the chips and transported to their final destinations through microfluidic channels.

In a remarkable demonstration of the utility of the daisy approach, the researchers have patterned two different genes as alternating stripes on a biochip. The protein synthesized on one stripe diffuses to the second stripe where it regulates the synthesis of a second protein. More complex artificial gene circuits can be envisioned by extending this protocol, and thus the biochips may be able to carry out complex cascaded information-processing functions, mimicking those in living organisms.

“This approach is a first step towards functional cell-free biochemical factories for synthesizing biomolecules and decision-making modules”, said Bar-Ziv. Amnon Buxboim, a Ph.D. student in Bar-Ziv's group and one of the primary researchers involved in this work, added that placing genes close to one another on a surface provides opportunities not available in bulk solution by allowing communication between individual gene sequences in these artificial cells.

Citation: Roy Bar-Ziv, A Single-Step Photolithographic Interface for Cell-Free Gene Expression and Active Biochips, Small 2006, 2, No. 3, doi: 10.1002/smll.200600489

Source: Wiley

Related stories:

Spit tests may soon replace many blood tests
One day soon patients may spit in a cup, instead of bracing for a needle prick, when being tested for cancer, heart disease or diabetes. A major step in that direction is the cataloguing of the “complete” salivary proteome, a set of proteins in human ductal saliva, identified by a consortium of three research teams, according to an article published today in the Journal of Proteome Research. Replacing blood draws with saliva tests promises to make disease diagnosis, as well as the tracking of treatment efficacy, less invasive and costly.
Biochips can detect cancers before symptoms develop
In their fight against cancer, doctors have just gained an impressive new weapon to add to their arsenal. Researchers at the U.S. Department of Energy's Argonne National Laboratory have developed a chip that can save lives by diagnosing certain cancers even before patients become symptomatic.
Biochip mimics the body to reveal toxicity of industrial compounds
A new biochip technology could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals, according to new findings from a team of researchers at Rensselaer Polytechnic Institute, the University of California at Berkeley, and Solidus Biosciences Inc.
HP Licenses Technology to Create Nanoscale Electronic Devices
HP today announced that it is beginning to reap returns from its 10-year investment in nanoscale electronics with the licensing of technology that could enable the fabrication of semiconductor chips significantly more powerful than those available today.
Plastic biochip speeds up protein detection
A new, fast, and inexpensive way to test for medically important molecules, such the blood clot protein thrombin and faulty proteins present in Alzheimer’s disease, could emerge from research published today in the journal Advanced Materials.
Research lights up biochip potential
New research from a University of Alberta optics expert is shining a light on some of the challenges facing lab-on-a-chip technology. Electrical engineering professor Dr. Jim McMullin has developed a new type of biochip, which may eliminate the need for the bulky technology to analyze the results of tests happening within the tiny channels of biochips.
Research Goes Online in Birck Nanotechnology Center 'Cleanroom'
The Birck Nanotechnology Center at Purdue University on Monday, June 12 opened its $10 million Scifres Nanofabrication Laboratory to researchers.
New sensor detects chemical, biological, nuclear and explosive materials
Engineers at the U.S. Department of Energy's Argonne National Laboratory, using an emerging sensing technology, have developed a suite of sensors for national security applications that can quickly and effectively detect chemical, biological, nuclear and explosive materials.

News discussion:

Nanotechnology news